How I plan to Brexit-proof my stocks and shares ISA

Do you fear Brexit will hit the value of your investments? Here’s how I think you can use it to your advantage.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With hardline Brexiteers sounding more like the Walmington-on-Sea Home Guard every day, it’s hardly surprising if private investors are getting nervous.

If we walk away from the EU with no agreement in place, an economic panic is almost certain — and then where would we be? I’m hoping common sense will prevail, but I’m also thinking of ways to reduce any adverse effects on my investment portfolio.

For me, the key approach is to think internationally, and going for FTSE 100 stocks will pretty much have that sorted anyway as the great majority of our top companies are global in their outlook. But you might want to keep away from domestic-focused stocks like banks and housebuilders.

Contrarian

I’m not shunning them myself as the contrarian in me thinks they’re oversold due to excessively pessimistic sentiment. But my investment in Lloyds Banking Group hasn’t been a roaring success so far, and if sleeping easy at night is key for you, then you might want to avoid those two sectors.

Among the more obvious international contenders are, I think, our top oil and pharmaceuticals companies, and I see BP, Royal Dutch Shell, AstraZeneca and GlaxoSmithKline as being pretty much immune to the vagaries of the UK economy.

Only around 25% of AstraZeneca’s turnover, for example, comes from the UK. GlaxoSmithKline is even better insulated, with a mere 5% or so generated on these shores.

Sterling

Those few bring me to two key considerations, world commodity prices and the value of the pound. Firstly, the harder our Brexit, the worse the impact on the currency is likely to be. But a falling pound should actually see share prices rising, as they reflect worldwide demand and are more closely tied to the US dollar than any other currency.

But more than that, commodities are priced in dollars, with the vast bulk of valuable dirt produced and consumed outside our islands. That means producers of oil, metals and minerals should be seeing the value of their revenues rising in sterling terms — and that should mean bigger profits and higher sterling share prices.

On that score, I’m happy with my investment in Sirius Minerals. It’s very much a UK-based company (with its potash assets in Yorkshire), but the sale agreements it has in place are with customers scattered around the globe. Sirius faces risks, but I don’t see Brexit as one of them.

Trusts

If you want more than ‘boring’ FTSE 100 shares, an option is to go for globally-based investment trusts. I love the idea of investment trusts anyway, where shareholders own all of their assets and there’s no conflict of interest between them and customers — because they’re one and the same. And they can provide a nice way to gain exposure to smaller global companies.

Lindsell Train Investment Trust, for example, has consistently been a strong performer, investing in a wide range of assets. Its shares are trading at a sizeable premium to net asset value, mind, so a lot of people probably have the same idea.

Witan Investment Trust and F&C Global Smaller Companies are two more with successful records, giving you options to target larger multinationals or smaller companies respectively. And there are plenty more great investment trusts out there.

Just remember one thing when it comes to Brexit — don’t panic.

Alan Oscroft owns shares of Lloyds Banking Group and Sirius Minerals. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two elderly people relaxing in the summer sunshine Box Hill near Dorking Surrey England
Investing Articles

Forget the FTSE 100 and come back after summer? Here’s my plan!

With the FTSE 100 moving around in a volatile way, should our writer just forget all about it for a…

Read more »

Young female hand showing five fingers.
Investing Articles

£20,000 invested in a Stocks and Shares ISA 5 years ago could now be worth…

The last five years have been something of a roller coaster for the markets. How would £20k in a Stocks…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Stock market correction: a once-in-a-decade chance to build big passive income?

Ben McPoland takes a closer look at a high-yield passive income stock from the FTSE 250 that investors have been…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

In volatile markets, could National Grid dividends be a safe haven?

National Grid offers a dividend yield well above the FTSE 100 and aims to keep growing its payout per share.…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Down 25%, are Barclays shares simply too cheap to ignore?

Barclays shares have given up a chunk of their recent gains since the Middle East powder keg ignited. Should investors…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

How much would someone need in an ISA to target a £1,000 monthly second income?

Christopher Ruane explains how someone could use an empty Stocks and Shares ISA to target a four-figure monthly second income…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Are investors taking a big gamble chasing Rolls-Royce shares higher and higher?

With Rolls-Royce shares having fallen back from their peak, the temptation to see this as a buying opportunity must be…

Read more »

Cargo containers with European Union and British flags reflecting Brexit and restrictions in export and import
Investing Articles

Down 70%, is Fevertree Drinks a share to consider buying at 815p?

Fevertree reported its 2025 earnings today and the investors liked what they saw. So is this a share to consider…

Read more »